World Sleep 2025: BlueSleep’s Dental Team on the Cutting Edge of Oral Appliance Therapy

BlueSleep’s model to diagnose and treat sleep apnea continues to drive down costs and increase access. For patients opting for oral appliance therapy (mandibular advancement devices), our dental team led by Alicia Jackson, DDS, Director of Oral Appliance Therapy and Research, ensures that patients receive a digital scan of their teeth at our clinic at 245 5th Avenue in New York, followed by the ordering and fitting of the best oral appliances paid for by medical insurance. 

Annual Review of Oral Appliances by the BlueSleep Dental Team

For three years the dental team has posted “Best Devices for Sleep Apnea: Oral Appliance Reviews” based on the oral appliances’ efficiency, comfort, maintenance, durability and warranty and advancement. The review includes devices made by Prosomnus, Panthera, Glidewell and Dynaflex. No other dentist or sleep specialists have conducted a review of oral appliances or continued to invest in original research on the effectiveness of oral appliance therapy.

Original Research on Oral Appliance Therapy

At World Sleep 2025 in Singapore Dr. Jackson and Bluesleep’s Founder and CEO, Jordan Stern, MD presented real-world, single-center results of a telemedicine workflow for the treatment of Obstructive Sleep Apnea and snoring using Mandibular Advancement Devices.

‍

This study reviewed 15,011 new sleep patients entering the sleep care pathway through the BlueSleep® digital platform and workflow, comparing pre and post treatment AHI (Apnea Hypopnea Index) scores for patients with mild, moderate, and severe OSA treated with ProSomnus devices.

Conclusions of the Research Study

The current state of OSA diagnosis and treatment requiring in person visits for consultations, sleep lab tests, and multiple in person visits for treatment can only serve a very small percentage of the at-risk population. This review suggests that a virtual workflow including telemedicine consultations, home sleep tests shipped to patients’ homes, and virtual delivery of MADs is feasible; and a valid alternative to the current in-person model. The virtual workflow is a scalable model that is rapid, affordable, effective, and can better serve the one billion people affected by OSA globally. 

What We Learn

>50% reduction in AHI with MAD in moderate and severe OSA

‍

Not all patients complete post treatment HST even when they already have the single use device in their home - likely due to cost issues

‍

An easier solution is needed for objective post treatment evaluation of OSA including wearables or integrated sensors in the OATs.

‍

We are updating this series as more patients complete their post treatment HSTs

About BlueSleep

BlueSleep is driving down the cost of care and increasing access for the diagnosis and treatment of snoring and sleep apnea. The company has completed over 40,000 telemedicine and in-person clinic visits and has adopted technologies such as single patient use and/or disposable home sleep testing; and virtual delivery of mandibular advancement devices and CPAP as treatment.

About Alicia Jackson, DDS, D-ABDSM

Dr. Alicia Jackson is a diplomate of the American Board of Dental Sleep Medicine, possessing extensive experience and expertise in the treatment of sleep-related breathing disorders, most notably through the administration of Oral Appliance Therapy (OAT). She has treated over 5,000 patients in the last few years of her career alone, demonstrating her skill and proficiency in the field.

‍

As the current Director of Oral Appliance Therapy and Research at BlueSleep, she plays a critical role. BlueSleep focuses on remote diagnosis and treatment of sleep-related breathing disorders using advanced telemedicine technology which she balances with the tangible nature of dentistry by utilizing a network of dentists for in-office evaluations and digital impressions followed by telemedicine deliveries of mandibular advancement devices. Dr. Jackson's leadership in oral appliance therapy and research is essential to the company's mission of providing accessible and effective treatment options for patients with sleep apnea and other sleep-disordered breathing conditions.

‍

Dr. Jackson has been a guest speaker on Sleep Disorders at World Sleep Day, an annual initiative dedicated to raising awareness of sleep health. She regularly shares her expertise on the diagnosis and treatment of sleep-disordered breathing, highlighting oral appliance therapy as a viable and conservative therapeutic modality.